Cancer Cachexia Market
Global Cancer Cachexia Market Worth $2.85 Billion by 2029: Combination Therapies Gaining Traction
March 20, 2024 11:13 ET | Research and Markets
Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. This research report sheds light...
biomerica.png
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
January 23, 2024 08:19 ET | Biomerica, Inc.
Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully built...
biomerica.png
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
December 18, 2023 07:47 ET | Biomerica, Inc.
Over 80% of gastric cancers are attributed to H. pylori bacterial infection Gastric cancer is the third most common cause of cancer related death in the world ...
Italo Tempera, Wistar Institute
Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
August 22, 2023 15:56 ET | The Wistar Institute
PHILADELPHIA, PA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results...
Global Gastrointestinal Diagnostics Market
Global Gastrointestinal Diagnostics Market to 2030: Increasing Prevalence of Gastrointestinal Disorders Drives Growth
April 04, 2023 11:04 ET | Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Gastrointestinal Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Endoscopy, Blood Test), by Technology, by Application, by...
TIP_link_300x300.jpg
Gastric Cancer Diagnostic Procedure Market Size Forecasts at 6.5% CAGR during (2022-2028) - Deep Dive Analysis of 18+ Countries across 5 Key Regions, 50+ Companies Scrutinized | The Insight Partners
March 02, 2023 09:55 ET | The Insight Partners
New York, March 02, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Gastric Cancer Diagnostic Procedure Market Size, Share, Growth, Trends and Global Forecasts to 2028 - COVID-19 Impact...
biomerica.png
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™
May 12, 2022 08:19 ET | Biomerica, Inc.
- Attaining CE Mark is a major step toward commercialization – - World Health Organization (WHO) lists H. pylori among the 16 antibiotic-resistant bacteria that pose the greatest threat to human...
biomerica.png
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population
April 26, 2022 08:19 ET | Biomerica, Inc.
Gastric cancer is the third most common cause of cancer related death in the world and over 80% of gastric cancers are attributed to H. pylori bacterial infection H. pylori infection is also a major...
Cancer Advances logo.jpg
Cancer Advances, Inc. Announces Publication, "Gastrin Vaccine Alone and in Combination with an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer" in Frontiers in Oncology
December 06, 2021 10:00 ET | Cancer Advances Inc
DURHAM, N.C., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces a new publication in...
22157.jpg
Tyrokinse Kinase Inhibitors in the Global Oncology Market 2021: Market Leaders by Indication and Product
November 05, 2021 05:58 ET | Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Oncology Markets for Tyrokinse Kinase Inhibitors" report has been added to ResearchAndMarkets.com's offering. Traditional cancer therapy has focused...